Ptc Therapeutics (PTCT) Deferred Taxes (2016 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Deferred Taxes of -$10000.0 in Q1 2026, down 1100.0% quarter-over-quarter from $1000.0 in Q4 2025, and down 600.0% on a YoY basis from $2000.0 in Q1 2025.
Ptc Therapeutics (PTCT) Deferred Taxes (2016 - 2026) Analysis & Trends
Ptc Therapeutics' Deferred Taxes history runs 6 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- In Q1 2026, Deferred Taxes fell 600.0% year-over-year to -$10000.0; the TTM figure through Mar 2026 stood at -$55.9 million (changed 0.01% YoY), while the FY2025 annual figure was -$3000.0, up 99.99% from the prior year.
- Deferred Taxes was -$10000.0 for Q1 2026 at Ptc Therapeutics, down from $1000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $4.0 million in Q4 2023 to a low of -$55.9 million in Q4 2024.
- Historically, Deferred Taxes has averaged -$9.3 million across 4 years, with a median of -$2000.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes plunged 1505.13% in 2024, then jumped 300.0% in 2025.
- A 4-year view of Deferred Taxes shows it stood at $4.0 million in 2023, then slumped by 1505.13% to -$55.9 million in 2024, then soared by 100.0% to $1000.0 in 2025, then sank by 1100.0% to -$10000.0 in 2026.
- The last three Deferred Taxes figures came in at -$10000.0 (Q1 2026), $1000.0 (Q4 2025), and $2000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -55.91 Mn |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 3.98 Mn |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -50.90 Mn |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2017 | 199,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Sep 30, 2016 | 22,000.00 |